On Friday, Cathie Wood-led Ark Invest made significant trades involving Beam Therapeutics Inc. BEAM, Nu Holdings Ltd. NU, MercadoLibre Inc. MELI, and Adaptive Biotechnologies Corp. ADPT.
The BEAM Trade
Ark Invest, through its ARK Genomic Revolution ETF ARKG and ARK Innovation ETF ARKK, bought a total of 24,640 shares of Beam Therapeutics.
This comes after the firm’s previous acquisition of Beam Therapeutics shares just a week prior. The value of this trade, calculated from the latest closing price is nearly $750,000.
The NU Trade
Ark Invest, through its ARK Fintech Innovation ETF ARKF, bought 162,143 shares of Nu Holdings Ltd. This marks a significant investment in the fintech company, reflecting Ark’s strategic positioning in the dynamic tech sector.
The value of this trade, calculated from the latest closing price is over $1.75 million.
The MELI and ADPT Trades
On the same day, Ark Invest also sold shares of MercadoLibre Inc and Adaptive Biotechnologies Corp. Through its ARK Fintech Innovation ETF, Ark sold 347 shares of MercadoLibre.
Meanwhile, through its ARK Genomic Revolution ETF, Ark offloaded 8,129 shares of Adaptive Biotechnologies.
Read Next:
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Ark Invest
Market News and Data brought to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
